Nonalcoholic Steatohepatitis: A Search for Factual Animal Models
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, which occurs in the absence of alcohol abuse. NAFLD can evolve into progressive liver injury and fibrosis in the form of nonalcoholic steatohepatitis (NASH). Several animal models have been developed to attempt to represent the morphological, biochemical, and clinical features of human NASH. The actual review presents a critical analysis of the most commonly used experimental models of NAFLD/NASH development. These models can be classified into genetic, nutritional, and a combination of genetic and nutritional factors. The main genetic models are ob/ob and db/db mutant mice and Zucker rats. The principal nutritional models employ methionine- and choline-deficient, high-fat, high-cholesterol and high-cholate, cafeteria, and high-fructose diets. Currently, associations between high-fructose and various compositions of high-fat diets have been widely studied. Previous studies have encountered significant difficulties in developing animal models capable of reproducing human NASH. Some models produce consistent morphological findings, but the induction method differs significantly compared with the pathophysiology of human NASH. Other models precisely represent the clinical and etiological contexts of this disease but fail to provide accurate histopathological representations mainly in the progression from steatosis to liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 The main mechanisms involved in the pathophysiology of the nonalcoholic steatohepatitis (NASH). FFA: free fatty acids; ROS: reactive oxygen species; TG: triglycerides (adapted from Angulo, 2002 [8]).](https://figures.cochat.ai/paper-figures/b42710eb3879438e98ec968c00dfef0a/nonalcoholic-steatohepatitis-a-search-for-factual-animal-models-figure-2.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The relevance of these models to humans is questionable because they most often essentialize isolated aspects of the human pathophysiology (6).”
From Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis (2016) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Ahima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077 · cited 1×
“Probably, lipid accumulation occurs in parallel with the generation of lipotoxic metabolites, which are primarily responsible for the progression of liver disease [19, 23].”
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Rolo, A. P., Teodoro, J. S., & Palmeira, C. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.003 · Cited by 955 · cited 1×
“In hepatic steatosis, the imbalance between scarce endogenous antioxidant reserves and augmented mitochondrial production of free radicals results in oxidative damage to lipids, proteins, and DNA with subsequent cell death [9, 10].”
Bedossa, P., Poitou, C., Veyrie, N., Bouillot, J.-L., Basdevant, A., Paradis, V., Tordjman, J., & Clement, K. (2012) · Hepatology · doi:10.1002/hep.25889 · Cited by 903 · cited 1×
“Another similar method for NASH grading is the SAF system, which comprises a semiquantitative score of steatosis (S), inflammatory activity (A), and fibrosis (F) [7].”
Fructose consumption as a risk factor for non-alcoholic fatty liver disease
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 863 · cited 1×
“In humans, increased levels of fructose consumption, primarily in the form of corn syrup for soft drinks, are associated with increased severity of hepatic steatosis and fibrosis [60, 61].”
Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L., & Brown, M. S. (1998) · Genes & Development · doi:10.1101/gad.12.20.3182 · Cited by 790 · cited 1×
“Similar to some forms of congenital lipodystrophies, the amount of systemic fat tissue is decreased, but the animals present significant hepatic lipid accumulation [27].”
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771 · cited 1×
“No published data on animals demonstrated that administration of fructose alone can alter themetabolic parameters associatedwithNASH, but fructose has been reported to alter potent biochemical properties involved in promoting insulin resistance [66].”
Cited by
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
Ipsen, D. H., Lykkesfeldt, J., & Tveden-Nyborg, P. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2860-6 · Cited by 1,471
“Noticeably, a major limitation of the current models utilizing Western diets, not employing micronutrient deficiency or abnormally high amounts of cholesterol, is the absence of progressive, advanced hepatic fibrosis [129].”
BackgroundNonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Hardy, T., Oakley, F., Anstee, Q. M., & Day, C. P. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044224 · Cited by 611
“Vital insights into the pathogenesis and underlying mechanisms of NAFLD have been gained from the study of existing animal models; detailed discussion is outside the scope of this article and is reviewed elsewhere (87) and summarized in Table 1.”
BackgroundA diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
Asgharpour, A., Cazanave, S. C., Pacana, T., Seneshaw, M., Vincent, R., Banini, B. A., Kumar, D. P., Daita, K., Min, H.-K., Mirshahi, F., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.005 · Cited by 538
“While a large number of models have been described, they have several limitations [2] (Supplementary Table 1).”
BackgroundChastin, S. F. M., De Craemer, M., De Cocker, K., Powell, L., Van Cauwenberg, J., Dall, P., Hamer, M., & Stamatakis, E. (2019) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-097563 · Cited by 465
Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
Van Herck, M., Vonghia, L., & Francque, S. (2017) · Nutrients · doi:10.3390/nu9101072 · Cited by 392
“It is generally accepted that the genetic mutation alone is not sufficient for the development of NASH and a second stimulus is needed in the form of a chemical challenge (including lipopolysaccharide, CCL4 and TAA administration) or dietary measures (including MCD diet and HFD) [28,62].”
BackgroundInfluentialFarrell, G., Schattenberg, J. M., Leclercq, I., Yeh, M. M., Goldin, R., Teoh, N., & Schuppan, D. (2019) · Hepatology · doi:10.1002/hep.30333 · Cited by 313
“geNetIc MoDelS Genetic models of NASH are summarized in Table 2 and described in detail in several reviews.(10,12,14,17-21) Voluntary overeating occurs in mice with single mutations of appetite-regulating genes, especially ob/ob (leptin-deficient), db/db (deficient leptin signaling), foz/foz (spontaneous mutations in…”
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Hansen, H. H., Feigh, M., Veidal, S. S., Rigbolt, K. T., Vrang, N., & Fosgerau, K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.007 · Cited by 270
Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research
Brown, Z. J., Heinrich, B., & Greten, T. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0033-6 · Cited by 245
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
Karkucińska‐Więckowska, A., Simões, I. C. M., Kalinowski, P., Lebiedzińska, M., Zieniewicz, K., Milkiewicz, P., Górska‐Ponikowska, M., Pinton, P., Malik, A. N., Krawczyk, M. J., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13622 · Cited by 197
Animal models of NAFLD from a hepatologist's point of view
Jahn, D., Kircher, S., Hermanns, H. M., & Geier, A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.023 · Cited by 194
Reversal of liver fibrosis: From fiction to reality
Zoubek, M. E., Trautwein, C., & Strnad, P. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.04.005 · Cited by 174
“High fat as well as methionine and choline-deficient (MCD) diets have been commonly used to reproduce NAFLD in rodents (30).”
BackgroundHuman hepatic 3D spheroids as a model for steatosis and insulin resistance
Kozyra, M., Johansson, I., Nordling, Å., Ullah, S., Lauschke, V. M., & Ingelman-Sundberg, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-32722-6 · Cited by 173
Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging
Gong, Z., Tas, E., Yakar, S., & Muzumdar, R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.022 · Cited by 144
Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases
Yu, Y., Cai, J., She, Z., & Li, H. (2019) · Advanced Science · doi:10.1002/advs.201801585 · Cited by 164
Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights
Stephenson, K., Kennedy, L. L., Hargrove, L. A., Demieville, J., Thomson, J., Alpini, G. D., & Francis, H. (2017) · Gene Expression · doi:10.3727/105221617x15093707969658 · Cited by 164
Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
Kostrzewski, T., Cornforth, T., Snow, S. A., Ouro-Gnao, L., Rowe, C., Large, E. M., & Hughes, D. J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i2.204 · Cited by 149
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis
Feaver, R. E., Cole, B. K., Lawson, M. J., Hoang, S. A., Marukian, S., Blackman, B. R., Figler, R. A., Sanyal, A. J., Wamhoff, B. R., & Dash, A. (2016) · JCI Insight · doi:10.1172/jci.insight.90954 · Cited by 153
“The relevance of these models to humans is questionable because they most often essentialize isolated aspects of the human pathophysiology (6).”
BackgroundThe deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis
Ji, Y., Huang, Z., Yang, X., Wang, X., Zhao, L., Wang, P., Zhang, X., Alves‐Bezerra, M., Cai, L., Zhang, P., et al. (2018) · Nature Medicine · doi:10.1038/nm.4461 · Cited by 149
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Hart, K. M., Fabre, T., Sciurba, J. C., Gieseck, R. L., Borthwick, L. A., Vannella, K. M., Acciani, T. H., de Queiroz Prado, R., Thompson, R. W., White, S., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3694 · Cited by 143
Rodent Models of Nonalcoholic Fatty Liver Disease
Zhong, F., Zhou, X., Xu, J., & Gao, L. (2019) · Digestion · doi:10.1159/000501851 · Cited by 136
Nonalcoholic fatty liver disease: a challenge from mechanisms to therapy.
Tarantino, G., Citro, V., & Capone, D. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010015 · Cited by 134
“Both db/db mice and fa/fa rats do not naturally progress to NASH, and require a further stimulus, as do ob/ob mice [70].”
BackgroundObese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
Kristiansen, M. N. B., Veidal, S. S., Rigbolt, K. T. G., Tølbøl, K. S., Roth, J. D., Jelsing, J., Vrang, N., & Feigh, M. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i16.673 · Cited by 124
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Soret, P.-A., Magusto, J., Housset, C., & Gautheron, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010036 · Cited by 121
“These rats develop severe obesity that leads to insulin resistance and hepatic steatosis [142,155].”
BackgroundHuang, C.-Z., Tung, Y., Hsia, S., Wu, C., & Yen, G. (2017) · Food & Function · doi:10.1039/c6fo01585a · Cited by 119
Li, Y., Huang, B., Jiang, X., Chen, W., Zhang, J., Wei, Y., Chen, Y., Lian, M., Bian, Z., Miao, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01994 · Cited by 107
“The steatosis and inflammation in HFD model are substantially less remarkable than MCD model (46).”
BackgroundNon-alcoholic fatty liver disease (NAFLD) models in drug discovery
Cole, B. K., Feaver, R. E., Wamhoff, B. R., & Dash, A. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1410135 · Cited by 79
Nonhuman Primates and Translational Research—Cardiovascular Disease
Cox, L. A., Olivier, M., Spradling‐Reeves, K. D., Karere, G. M., Comuzzie, A. G., & VandeBerg, J. L. (2017) · ILAR Journal · doi:10.1093/ilar/ilx025 · Cited by 82
“Also, despite the effects of challenge diets, rodents do not readily develop fibrosis (Bergen and Mersmann 2005; Ketloy et al. 2008; Sanches et al. 2015; Seok et al. 2013).”
BackgroundKořínková, L., Pražienková, V., Černá, L., Karnošová, A., Železná, B., Kuneš, J., & Maletínská, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.597583 · Cited by 81
Zhang, Y., Deng, Y., Tang, K., Chen, R.-S., Shu, L., Liang, Y., Li, H., Jin, L., Liang, Z., Chen, Y., et al. (2019) · Current Medical Science · doi:10.1007/s11596-019-1997-3 · Cited by 80
Bioactivity of peptides obtained from poultry by-products: A review
Romero-Garay, M. G., Montalvo‐González, E., Hernández-González, C., Soto‐Domínguez, A., Becerra-Verdín, E. M., & García‐Magaña, M. D. L. (2021) · Food Chemistry X · doi:10.1016/j.fochx.2021.100181 · Cited by 79
“When an oxidative stress environment is generated, overproduction of reactive oxygen species (ROS) is obtained, mainly in the form of H2O2, which denotes damage to lipids, proteins, DNA, and consequent cell death (apoptosis) (Sanches et al., 2015).”
BackgroundGuantario, B., Giribaldi, M., Devirgiliis, C., Finamore, A., Colombino, E., Capucchio, M. T., Evangelista, R., Motta, V., Zinno, P., Cirrincione, S., et al. (2020) · Nutrients · doi:10.3390/nu12072147 · Cited by 78
“While the control diet contained exclusively plant origin lipids, the milk-based diets were characterised by a significant amount of animal fats, with a higher saturated fatty acid content [25].”
BackgroundA Microphysiological System for Studying Nonalcoholic Steatohepatitis
Kostrzewski, T., Maraver, P., Ouro‐Gnao, L., Levi, A., Snow, S., Miedzik, A., Rombouts, K., & Hughes, D. (2020) · Hepatology Communications · doi:10.1002/hep4.1450 · Cited by 77
Bilberry Anthocyanins Ameliorate NAFLD by Improving Dyslipidemia and Gut Microbiome Dysbiosis
Nakano, H., Wu, S., Sakao, K., Hara, T., He, J., García, S., Shetty, K., & Hou, D. (2020) · Nutrients · doi:10.3390/nu12113252 · Cited by 77
“Oxidative stress is associated with the progression of NAFLD [22].”
BackgroundPancreatic and mucosal enzymes in choline phospholipid digestion
Nilsson, Å., & Duan, R. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00320.2018 · Cited by 74
Henkel, J., Coleman, C. D., Schraplau, A., Jöhrens, K., Weber, D., Castro, J. P., Hugo, M., Schulz, T. J., Krämer, S., Schürmann, A., et al. (2017) · Molecular Medicine · doi:10.2119/molmed.2016.00203 · Cited by 62
Sebastiani, M., Triantafyllias, K., Manfredi, A., González-Gay, M. Á., Palmou‐Fontana, N., Cassone, G., Drott, U., Delbrück, C., Rojas‐Serrano, J., Bertolazzi, C., et al. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.180355 · Cited by 70
Chen, H. L., Tsai, T. C., Tsai, Y. C., Liao, J. W., Yen, C. C., & Chen, C. M. (2016) · Nutrition & Diabetes · doi:10.1038/nutd.2016.49 · Cited by 64
Animal models of NAFLD from the pathologist's point of view
Denk, H., Abuja, P. M., & Zatloukal, K. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.024 · Cited by 68
An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Marin, V., Rosso, N., Ben, M. D., Raseni, A., Boschelle, M., Degrassi, C., Němečková, I., Nachtigal, P., Avellini, C., Tiribelli, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158817 · Cited by 67
“Often, these differences have been made on purpose to investigate the consequences and the biomolecular mechanisms elicited by specific components present on the diet on the development of diabetes, atherosclerosis or different degrees of liver damage, goal that usually is well accomplished [18,20,35,36].”
BackgroundAn Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present
Jacobs, A., Warda, A., Verbeek, J., Cassiman, D., & Spincemaille, P. (2016) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.3 · Cited by 57
Chiba, T., Suzuki, S., Sato, Y., Itoh, T., & Umegaki, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164191 · Cited by 55
Goh, Y. Q., Cheam, G., & Wang, Y. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03077 · Cited by 61
Nonalcoholic Fatty Liver Disease
Berk, P. D., & Verna, E. C. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.007 · Cited by 60
Common cellular origin and diverging developmental programs for different sesamoid bones
Eyal, S., Rubin, S., Krief, S., Levin, L., & Zelzer, E. (2019) · Development · doi:10.1242/dev.167452 · Cited by 59
Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study
Azarang, A., Farshad, O., Ommati, M. M., Jamshidzadeh, A., Heidari, R., Abootalebi, S. N., & Gholami, A. (2020) · BioMed Research International · doi:10.1155/2020/5487659 · Cited by 55
“Also, oxidative stress has been reportedly associated with the pathogenesis of NAFLD [43, 44], and the improved results reveal the critical role of probiotics in the prevention of NAFLD.”
ResultKostrzewski, T., Snow, S., Battle, A. L., Peel, S., Ahmad, Z., Basak, J., Surakala, M., Bornot, A., Lindgren, J., Ryaboshapkina, M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02616-x · Cited by 52
Durkin, S. J., Broun, K., Spittal, M. J., & Wakefield, M. A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024267 · Cited by 50
Enhanced Steatosis and Fibrosis in Liver of Adult Offspring Exposed to Maternal High-Fat Diet
Thompson, M. D., Cismowski, M. J., Trask, A. J., Lallier, S. W., Graf, A. E., Rogers, L. K., Lucchesi, P. A., & Brigstock, D. R. (2016) · Gene Expression · doi:10.3727/105221616x692135 · Cited by 42
Fatty liver promotes fibrosis in monkeys consuming high fructose
Cydylo, M. A., Davis, A. T., & Kavanagh, K. (2017) · Obesity · doi:10.1002/oby.21720 · Cited by 44
“Rodents also have dissimilar primary sites of lipogenesis, inflammatory responses, and toll-like receptor expression patterns, and they do not readily develop hepatic fibrosis, which is the disease feature that is the most difficult to induce experimentally and is without therapeutic options in people (4,6-8).”
BackgroundER Stress-induced Inflammasome Activation Contributes to Hepatic Inflammation and Steatosis
Zhang, J., Zhang, K., Li, Z., & Guo, B. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000457 · Cited by 47
“Non-alcoholic fatty liver disease (NAFLD), a spectrum of metabolic disorders ranging from steatosis (NAFL) to steatohepatitis (NASH) to cirrhosis, is the foremost cause of non-alcoholic and nonviral liver-associated illness and death in the developed countries [6].”
BackgroundInfluentialNanoliposome Improves Inhibitory Effects of Naringenin on Nonalcoholic Fatty Liver Disease in Mice
Chen, C., Xu, J., Ou, Y., Cao, Y., Xu, L., Wang, Y., & Qi, R. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0119 · Cited by 48
Mouse models of non‐alcoholic steatohepatitis: A reflection on recent literature
Haczeyni, F., Yeh, M. M., Ioannou, G. N., Leclercq, I. A., Goldin, R. D., Dan, Y. Y., Yu, J. Q., Teoh, N., & Farrell, G. C. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14122 · Cited by 48
Longo, L., Ferrari, J. T., Rampelotto, P. H., Dellavia, G. H., Pasqualotto, A., de Oliveira, C. P. M. S., Cerski, C. T. S., da Silveira, T. R., Cruz, C. U., & Álvares‐da‐Silva, M. R. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s262879 · Cited by 48
Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice
Han, X., Chen, D., Zhong, Y., Zhou, Z., Fang, S., Li, M., & Guo, C. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13174 · Cited by 43
A diet-induced Sprague–Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis
Ichimura‐Shimizu, M., Masuzumi, M., Kawase, M., Sakaki, M., Tamaru, S., Nagata, Y., Tanaka, K., Suruga, K., Tsuneyama, K., Matsuda, S., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.10.007 · Cited by 42
“Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of alcohol abuse and is now the most common etiology of chronic liver disease globally [3].”
BackgroundKimura, K., Inaba, Y., Watanabe, H., Matsukawa, T., Matsumoto, M., & Inoue, H. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12964 · Cited by 42
Sun, G., Jackson, C. V., Zimmerman, K. M., Zhang, L., Finnearty, C., Sandusky, G. E., Zhang, G., Peterson, R. G., & Wang, Y. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-0958-4 · Cited by 41
“In recent reviews [12, 44], the murine models that most closely resembled the human disease, were those that used high fat diets supplemented with fructose.”
BackgroundAhmed, L. A., Salem, M. B., el-Din, S. H. S., El-Lakkany, N. M., Okasha, H., Nasr, S. M., Hammam, O. A., Botros, S. S., & Saleh, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173461 · Cited by 41
Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models
Mahmoudi, A. A., Moallem, S. A., Johnston, T. P., & Sahebkar, A. (2022) · PPAR Research · doi:10.1155/2022/5805398 · Cited by 40
“As an aside, the steatosis and inflammation that arise upon consumption of a HFD are typically less severe than that observed in animals fed the methionine choline-deficient (MCD) diet, which will be discussed in a later section [37].”
BackgroundPathogenesis of and major animal models used for nonalcoholic fatty liver disease
Jiang, M., Wu, N., Chen, X., Wang, W., Chu, Y., Liu, H., Li, W., Chen, D., Li, X., & Xu, B. (2019) · Journal of International Medical Research · doi:10.1177/0300060519833527 · Cited by 40
“db/db mice are obese and diabetic and develop macrovesicular hepatic steatosis accompanied by hyperglycaemia and hyperinsulinaemia.(74,75) Unlike ob/ob mice, db/db mice exhibit normal or elevated levels of leptin but are resistant to its effects.”
BackgroundInfluentialSalouti, R., Zamani, M., Ghoreyshi, M., Dapena, I., Melles, G. R. J., & Nowroozzadeh, M. H. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-313365 · Cited by 39
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
Savari, F., Mard, S. A., Badavi, M., Rezaie, A., & Gharib-Naseri, M. K. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1041-x · Cited by 35
Macrophages and the development and progression of non-alcoholic fatty liver disease
Alabdulaali, B., Al‐Rashed, F., Al‐Onaizi, M., Kandari, A., Razafiarison, J., Tonui, D., Williams, M. R., Blériot, C., Ahmad, R., & Alzaïd, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1195699 · Cited by 39
Chen, X., Xu, Y., Zhao, D., Chen, T., Gu, C., Yu, G., Chen, K., Zhong, Y., He, J., Liu, S., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00888 · Cited by 38
Gong, Y., Liu, Z., Zhang, Y., Zhang, J., Yin, Z., & Wu, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01477-z · Cited by 38
“However, hyperglycemia and NASH occur simultaneously, which makes it impossible to assess the effects of diabetes on preexisting NASH [49, 50].”
Varela‐López, A., Bullón, P., Ramírez-Tortosa, C. L., Navarro‐Hortal, M. D., Robles-Almazán, M., Bullón, B., Cordero, M. D., Battino, M. A., & Quiles, J. L. (2020) · Nutrients · doi:10.3390/nu12051405 · Cited by 36
“This is truly relevant because of the difficulties in identifying an accurate model of human NASH in rodents [38].”
BackgroundCamacho, R. C., Polidori, D., Chen, T., Chen, B., Hsu, H. H., Gao, B., Marella, M., Lubomirski, M. S., Beavers, T., Cabrera, J., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14955 · Cited by 35
“Most placebotreated subjects in the human study with normalized levels of ALT continued having severe histological abnormalities, reaffirming that ALT per se cannot be used as a surrogate marker to monitor response to pharmacological interventions in NASH.”
BackgroundInfluentialEffect of various factors on the induction of liver tumors in animals by quinoline.
Shinohara, Y., Ogiso, T., Hananouchi, M., Nakanishi, K., Yoshimura, T., & Ito, N. (1977) · PubMed · Cited by 35
Guo, C., Han, X., Guo, T., Zhang, W., Xuan, W.-Q., Ren, Y.-T., Wang, D., Chen, Y.-H., Meng, Y., Gao, H., et al. (2020) · Food & Function · doi:10.1039/d0fo00910e · Cited by 34
Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats
Aguirre, L., Palacios-Ortega, S., Fernández‐Quintela, A., Hijona, E., Bujanda, L., & Portillo, M. P. (2019) · Nutrients · doi:10.3390/nu11050961 · Cited by 34
“Many metabolic syndrome features, such as hyperphagia, hyperglycemia, hyperinsulinemia, hypercholesterolemia, adipocyte hypertrophy, and hyperplasia, and muscle atrophy are also observed in this model [5].”
BackgroundNieves, A. S., Salas‐Silva, S., Chávez-Rodríguez, L., Escobedo‐Calvario, A., Desoteux, M., Bucio, L., Souza, V., Miranda-Labra, R. U., Muñoz-Espinosa, L. E., Coulouarn, C., et al. (2021) · Cancers · doi:10.3390/cancers13071721 · Cited by 34
“Steatohepatitis was defined by the presence of steatosis, inflammation and hepatocellular ballooning [24], as per the FLIP algorithm [25].”
Pepsin egg white hydrolysate ameliorates metabolic syndrome in high-fat/high-dextrose fed rats
Moreno-Fernández, S., Garcés‐Rimón, M., González, C., Uranga, J. A., López‐Miranda, V., Vera, G., & Miguel, M. (2018) · Food & Function · doi:10.1039/c7fo01280b · Cited by 33
How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?
Mann, J. P., Semple, R. K., & Armstrong, M. J. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00145 · Cited by 32
Gómez-Zorita, S., Milton‐Laskibar, I., Macarulla, M. T., Biasutto, L., Fernández‐Quintela, A., Miranda, J., Lasa, A., Segues, N., Bujanda, L., & Portillo, M. P. (2021) · Food & Function · doi:10.1039/d0fo03320k · Cited by 31
Sarr, O., Blake, A., Thompson, J. A., Zhao, L., Rabicki, K., Walsh, J. C., Welch, I. D., & Regnault, T. R. H. (2015) · The Journal of Physiology · doi:10.1113/jp271777 · Cited by 31
“In addition, stimulation of hepatic stellate cells (HSCs) with TGFB1 production resulted in upregulation of MMP2 expression and activity (Yang et al. 2003), and, in severe hepatic fibrosis, MMP2 gene expression and activity are increased (Takahara et al. 1995), accelerating disease progression through degradation of n…”
BackgroundInfluentialIchimura‐Shimizu, M., Watanabe, S., Kashirajima, Y., Nagatomo, A., Wada, H., Tsuneyama, K., & Omagari, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169268 · Cited by 30
“The prevalence of NAFLD is estimated to reach 30% of adults in developed countries, and more than 10% of cases progress to having hepatic lesions including lobular inflammation, hepatocyte degeneration or “ballooning”, and fibrosis in addition to fat deposition, which are hallmarks of NASH [4].”
BackgroundPalladini, G., Pasqua, L. G. D., Berardo, C., Siciliano, V., Richelmi, P., Perlini, S., Ferrigno, A., & Vairetti, M. (2019) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2019/5413461 · Cited by 30
“In addition to cellular damage by massive membrane lipoperoxidation, as demonstrated by elevated TBARS, ROS can act as second messengers in the control of genes encoding proinflammatory cytokines such as TNFalpha [5].”
BackgroundMethodInfluentialZhen, Q., Liang, Q., Wang, H., Zheng, Y., Lu, Z., Bian, C., Zhao, X., & Guo, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1118925 · Cited by 29
“Mice fed with MCD diet develop severe hepatic steatosis, which is manifested by increased hepatic triglyceride levels (27, 28).”
BackgroundSimões, I. C. M., Janikiewicz, J., Bauer, J., Karkucińska‐Więckowska, A., Kalinowski, P., Dobrzyń, A., Wolski, A., Pronicki, M., Zieniewicz, K., Dobrzyń, P., et al. (2019) · Nutrients · doi:10.3390/nu11122871 · Cited by 29
“Fructose, in particular, is known for its lipogenic properties and for the aggravation of glucose and fat metabolism disorders, leading to increased visceral fat deposition, liver TG accumulation and insulin resistance [92,164].”
BackgroundNon-alcoholic fatty liver disease–a chronic disease of the 21st century
Metrakos, P. P., & Tommy, N. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160153 · Cited by 28
Henkel, J., Buchheim-Dieckow, K., Castro, J. P., Laeger, T., Wardelmann, K., Kleinridders, A., Jöhrens, K., & Püschel, G. P. (2019) · Nutrients · doi:10.3390/nu11112709 · Cited by 27
Mitochondrial uncoupling has no effect on microvascular complications in type 2 diabetes
Hinder, L. M., Sas, K. M., O’Brien, P. D., Backus, C., Kayampilly, P. P., Hayes, J. M., Lin, C., Zhang, H., Shanmugam, S., Rumora, A. E., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37376-y · Cited by 27
Kandasamy, R., Constantinou, M., Rogers, S., Sandhu, S. S., Wickremasinghe, S., Al‐Qureshi, S., & Lim, L. L. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-313437 · Cited by 27
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention
Rabiu, L., Zhang, P., Afolabi, L. O., Saliu, M. A., Dabai, S. M., Suleiman, R. B., Gidado, K. I., Ige, M. A., Ibrahim, A., Zhang, G., et al. (2024) · Journal of Gastroenterology · doi:10.1007/s00535-024-02157-0 · Cited by 26
“Within rodent models, different dietary and chemical induction approaches (e.g., high-fat diet (HFD), methionine-and choline-deficient (MCD), and carbon tet-rachloride (CCl 4 ) induction) [86] have yielded conflicting insights into immune cell roles, further complicating our understanding.”
Ponnusamy, S., Tran, Q. T., Thiyagarajan, T., Miller, D. D., Bridges, D., & Narayanan, R. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370216688569 · Cited by 26
“The MCD diet reproduces most of the histopathological features of NASH, including an increase in serum transaminases.(21,22,30) However, the MCD does not reproduce the obesity and insulin resistance phenotypes that are characteristics of NASH in patients, rather reduces body weight.”
BackgroundZhang, L., Wu, X., Liao, S., Li, Y., Zhang, Z., Chang, Q., Xiao, R., & Liang, B. (2016) · Biology Open · doi:10.1242/bio.020875 · Cited by 25
“Regardless of the types of animal models used, the common characteristics are hepatic steatosis accompanied by obesity, dyslipidemia, hyperglycemia, insulin resistance and hyperinsulinemia (Anstee and Goldin, 2006; Ibrahim et al., 2015; Kucera and Cervinkova, 2014; Sanches et al., 2015), which largely reflect the hist…”
BackgroundHeo, Y. J., Choi, S., Lee, N., Jeon, J. Y., Han, S. J., Kim, D. J., KANG, Y. Y., Lee, K. W., & Kim, H. J. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15465 · Cited by 25
Zeng, Z., Zhou, Y., Xu, Y., Wang, S., Wang, B., Zeng, Z., Wang, Q., Ye, X., Lu, J., Yue, M., et al. (2022) · Food & Function · doi:10.1039/d1fo03170h · Cited by 24
Cruces‐Sande, M., Vila‐Bedmar, R., Arcones, A. C., González‐Rodríguez, Á., Rada, P., Gutiérrez-de-Juan, V., Vargas‐Castrillón, J., Iruzubieta, P., Sánchez‐González, C., Formentini, L., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.027 · Cited by 24
“Methionine and choline are essential for liver beta-oxidation and VLDL (very low density lipoproteins) production, and their deficiency results in hepatic steatosis, inflammation and fibrosis [16, 17].”
BackgroundDong, Y., Lu, H., Li, Q., Qi, X., Li, Y., Zhang, Z., Chen, J., & Ren, J. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116644 · Cited by 24
Kondo, Y., & Ishigami, A. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12722 · Cited by 23
Duparc, T., Briand, F., Trenteseaux, C., Mérian, J., Combes, G., Najib, S., Sulpice, T., & Martinez, L. O. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00139.2019 · Cited by 24
Acosta-Cota, S. D. J., Aguilar‐Medina, M., Ramos‐Payán, R., Ruiz-Quiñónez, A. K., Romero-Quintana, J. G., Montes‐Ávila, J., Rendón-Maldonado, J. G., Sánchez‐López, A., Centurión, D., & Osuna‐Martínez, U. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0353 · Cited by 22
Garay-Lugo, N., Domínguez‐López, A., Miliar-García, Á., Barrera, E. S. A., Gómez‐López, M., Alcalá, A. G., Martínez–Godínez, M. D. L. Á., & Lara‐Padilla, E. (2016) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2016.1208221 · Cited by 23
Rafiei, H., Yeung, M., Kowalski, S., Krystal, G., & Elisia, I. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1234300 · Cited by 21
Chen, W., Liu, W.-R., Hou, J., Ding, J., Peng, Z., Gao, S., Dong, X. W., Ma, J., Lin, Q., Lu, J., et al. (2019) · Bioscience Reports · doi:10.1042/bsr20181833 · Cited by 21
Ferredoxin 1 is essential for embryonic development and lipid homeostasis
Mohibi, S., Zhang, Y., Perng, V., Chen, M., Zhang, J., & Chen, X. (2024) · eLife · doi:10.7554/elife.91656 · Cited by 21
Reis, D. D., Fraticelli, L., Bassand, A., Manzo‐Silberman, S., Peschanski, N., Charpentier, S., Elbaz, M., Savary, D., Bonnefoy‐Cudraz, E., Laribi, S., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-022776 · Cited by 21
Brain‐derived neurotrophic factor knock‐out mice develop non‐alcoholic steatohepatitis
Ichimura‐Shimizu, M., Kojima, M., Suzuki, S., Miyata, M., Osaki, Y., Matsui, K., Mizui, T., & Tsuneyama, K. (2023) · The Journal of Pathology · doi:10.1002/path.6204 · Cited by 20
“Notably, despite the generation of NASH model animals for several years, the comprehensive phenotypes of NASH, including hepatic steatosis, in fl ammation, and fi brosis, are rarely fully replicated [24,25].”
BackgroundZimny, S., Pohl, R., Rein‐Fischboeck, L., Haberl, E. M., Krautbauer, S., Weiß, T. S., & Buechler, C. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.06.001 · Cited by 20
Metadata
- Authors
- Sanches, S. C. L., Ramalho, L. N. Z., Augusto, M. J., da Silva, D. M., & Ramalho, F. S.
- Affiliations
- Universidade de São Paulo (BR)
- Department of Pathology, School of Medicine of Ribeirão Preto, University of São Paulo, Avenida Bandeirantes 3900, Monte Alegre, 14049-900 Ribeirão Preto, SP, Brazil
- Corresponding author
- Ramalho, Fernando Silva
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-13
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC4433658
- OpenAlex
- W1969807612
- Cited by
- 174
- References
- 74
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 10 · 2023: 8 · 2022: 15 · 2021: 16 · 2020: 21 · 2019: 30 · 2018: 24 · 2017: 19 · 2016: 24 · 2015: 2
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (160028/2012-4)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, animal models, hepatic steatosis, liver fibrosis, ob/ob mice, db/db mice, Zucker rats, methionine-choline-deficient diet, high-fat diet, high-fructose diet, cafeteria diet, high-cholesterol diet, genetic models, nutritional models
- MeSH terms
- Animals, Disease Models, Animal, Humans, Liver Cirrhosis, Disease Progression, Mice, Rats, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.